CD169 (Siglec-1) as a Robust Human Cell Biomarker of Toll-Like Receptor 9 Agonist Immunotherapy.
Lende SSF, Pahus MH, Monrad I, Olesen R, Mahr AR, Vibholm LK, Østergaard L, Søgaard OS, Andersen AHF, Denton PW, Tolstrup M.
Lende SSF, et al. Among authors: tolstrup m.
Front Cell Infect Microbiol. 2022 Jul 5;12:919097. doi: 10.3389/fcimb.2022.919097. eCollection 2022.
Front Cell Infect Microbiol. 2022.
PMID: 35865810
Free PMC article.